CJC-1295 No DAC

Description

CJC-1295 No DAC, also known as Modified GRF (1-29), is a tetrasubstituted analog of the 1-29 fragment of growth hormone-releasing hormone, lacking the drug-affinity complex (DAC) that extends half-life in the standard CJC-1295. It is referenced in published in vitro laboratory research examining GHRH receptor binding kinetics and pituitary somatotrope cell culture assays.

Plumeo Research supplies CJC-1295 No DAC in lyophilized form at ≥99% purity, synthesized by SPPS and verified by HPLC and mass spectrometry. A Certificate of Analysis accompanies every batch.

Intended exclusively for in vitro laboratory research by qualified investigators. Not for human, veterinary, or clinical use.

Areas of Research Interest

• GHRH receptor binding and kinetics assays
• Pituitary somatotrope cell culture research
• cAMP signaling within the somatotropic axis
• Receptor pharmacology and affinity studies
• In vitro endocrinology cell models

Technical Properties

• Class: Modified GRF (1-29), no DAC
• Molecular Formula: C152H252N44O42
• Molecular Weight: 3367.9 g/mol
• CAS Number: 863288-34-0
• Purity: ≥99% (HPLC verified)
• Appearance: White lyophilized powder

Storage & Handling

• Store lyophilized product at -20°C, protected from light and moisture.
• Once reconstituted, store at 2–8°C and use within the recommended stability window.
• Avoid repeated freeze-thaw cycles to preserve peptide integrity.
• Handle in accordance with standard laboratory safety practices (PPE, sterile technique).
• Verify molecular data against the supplied Certificate of Analysis (COA) before use.

FOR LABORATORY AND RESEARCH USE ONLY. Not for human consumption, therapeutic use, veterinary use, or in vivo diagnostic procedures. Not a drug, food, or cosmetic. Products are sold exclusively to qualified researchers and laboratory professionals for in vitro investigational purposes. By purchasing, the buyer affirms they are a licensed researcher and assume full responsibility for proper handling, use, and disposal in compliance with all applicable laws.